Cyproterone Acetate for Topical Treatment of Androgen-Dependent Diseases

    January 2006
    Jana tecová
    New to Cyproterone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that CPA-loaded nanoparticles, particularly SLN formulations, increased CPA epidermal penetration compared to a conventional cream and may reduce side effects in treating androgen-dependent conditions. Our plain-language summary of this paper — not a Tressless recommendation.

    We don't know much about this study yet.

    Discuss this study in the Community →